Arbutus biopharma, x-chem and proteros biostructures enter into a pan-coronavirus discovery research and license agreement

Collaboration formed to accelerate the discovery of novel oral inhibitors targeting the sars-cov-2 nsp5 main protease for the treatment of covid-19 and potential future coronavirus outbreaks
ABUS Ratings Summary
ABUS Quant Ranking